These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 26471228)
1. Methods Report: European S3-Guidelines on the systemic treatment of psoriasis vulgaris--update 2015--EDF in cooperation with EADV and IPC. Nast A; Jacobs A; Rosumeck S; Werner RN J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):e1-22. PubMed ID: 26471228 [No Abstract] [Full Text] [Related]
2. European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC. Nast A; Gisondi P; Ormerod AD; Saiag P; Smith C; Spuls PI; Arenberger P; Bachelez H; Barker J; Dauden E; de Jong EM; Feist E; Jacobs A; Jobling R; Kemény L; Maccarone M; Mrowietz U; Papp KA; Paul C; Reich K; Rosumeck S; Talme T; Thio HB; van de Kerkhof P; Werner RN; Yawalkar N J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2277-94. PubMed ID: 26481193 [No Abstract] [Full Text] [Related]
3. European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC. Nast A; Spuls PI; van der Kraaij G; Gisondi P; Paul C; Ormerod AD; Saiag P; Smith CH; Dauden E; de Jong EM; Feist E; Jobling R; Maccarone M; Mrowietz U; Papp KA; Reich K; Rosumeck S; Talme T; Thio HB; van de Kerkhof P; Werner RN; Dressler C J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):1951-1963. PubMed ID: 28895202 [No Abstract] [Full Text] [Related]
4. Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast. Gooderham M; Papp K BioDrugs; 2015 Oct; 29(5):327-39. PubMed ID: 26481941 [TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis. Rouse NC; Farhangian ME; Wehausen B; Feldman SR Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):877-84. PubMed ID: 26488186 [TBL] [Abstract][Full Text] [Related]
8. Infections in the era of immunobiologicals. Romiti R; Hirayama ALDS; Porro AM; Gonçalves HS; Miot LDB; Durães SMB; Marques SA An Bras Dermatol; 2024; 99(2):167-180. PubMed ID: 38238209 [TBL] [Abstract][Full Text] [Related]
9. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070 [TBL] [Abstract][Full Text] [Related]
10. Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus. Damiani G; Amerio P; Bardazzi F; Carrera CG; Conti A; Cusano F; Dapavo P; DeSimone C; El Hachem M; Fabbrocini G; Gisondi P; Loconsole F; Micali G; Neri I; Parodi A; Piaserico S; Romanelli M; Stingeni L; ; Pigatto PDM Dermatol Ther (Heidelb); 2023 Jun; 13(6):1219-1241. PubMed ID: 37210684 [TBL] [Abstract][Full Text] [Related]
11. Exploring the perspective of patients with immune-mediated inflammatory diseases and care providers on the use of immunomodulatory drugs in infections: an interview study. Opdam MAA; Vriezekolk JE; Broen J; den Broeder AA; Verhoef LM Rheumatol Adv Pract; 2023; 7(1):rkad003. PubMed ID: 36685994 [TBL] [Abstract][Full Text] [Related]
13. Pros and cons of using systemic acitretin in the paediatric population. Sadowska M; Narbutt J; Skibińska M; Lesiak A Postepy Dermatol Alergol; 2022 Feb; 39(1):34-38. PubMed ID: 35369612 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document. Belinchón Romero I; Dauden E; Ferrándiz Foraster C; González-Cantero Á; Carrascosa Carrillo JM Ann Med; 2021 Dec; 53(1):1727-1736. PubMed ID: 34601988 [TBL] [Abstract][Full Text] [Related]
17. Effects of moving cupping therapy for plaque psoriasis: study protocol for a randomized multicenter clinical trial. Xing M; Yan X; Yang S; Li L; Gong L; Liu H; Xu R; Chen J; Ying L; Zhao Y; An Y; Liu Y; Huang G; Guo F; Yin Q; Wang R; Li B; Li X Trials; 2020 Feb; 21(1):229. PubMed ID: 32102679 [TBL] [Abstract][Full Text] [Related]
19. Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities? Baumgart DC; Misery L; Naeyaert S; Taylor PC Front Pharmacol; 2019; 10():279. PubMed ID: 30983996 [TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis. Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]